Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500 Futures
(0.16%) 5 335.75 points
Dow Jones Futures
(0.07%) 40 165 points
Nasdaq Futures
(0.24%) 18 681 points
Oil
(-0.54%) $79.63
Gas
(2.13%) $2.68
Gold
(0.38%) $2 426.60
Silver
(0.58%) $31.44
Platinum
(-1.50%) $1 073.60
USD/EUR
(0.09%) $0.921
USD/NOK
(0.11%) $10.69
USD/GBP
(0.05%) $0.787
USD/RUB
(-0.34%) $90.66

Realtime updates for Karuna Therapeutics Inc [KRTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
82.35%
return 4.31%
SELL
47.06%
return -0.68%
Last Updated15 Mar 2024 @ 16:00
25% discount on Stockinvest.us - Use code: Podcast

0.03% $ 329.83

BUY 94824 min ago

@ $329.82

Issued: 15 Mar 2024 @ 11:55

Return: 0.00%

Previous signal: Mar 15 - 09:30

Previous signal: Sell

Return: -0.04 %

Live Chart Being Loaded With Signals

Commentary (15 Mar 2024 @ 16:00):

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions...

Stats
Today's Volume 1.28M
Average Volume 971 825
Market Cap 12.60B
EPS $0 ( 2024-05-02 )
Next earnings date ( $0 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -28.09
ATR14 $4.03 (1.22%)
Insider Trading
Date Person Action Amount type
2024-03-18 Wheadon David E. Sell 990 Common Stock
2024-03-18 Wheadon David E. Sell 25 000 Option (right to buy)
2024-03-18 Wheadon David E. Sell 8 500 Option (right to buy)
2024-03-18 Wheadon David E. Sell 5 000 Option (right to buy)
2024-03-18 Wheadon David E. Sell 1 904 Option (right to buy)
INSIDER POWER
-93.84
Last 100 transactions
Buy: 115 486 | Sell: 3 548 924

Volume Correlation

Long: 0.41 (neutral)
Short: 0.44 (neutral)
Signal:(75.401) Neutral

Karuna Therapeutics Inc Correlation

10 Most Positive Correlations
SPLK0.842
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Karuna Therapeutics Inc Correlation - Currency/Commodity

The country flag -0.09
( neutral )
The country flag 0.64
( weak )
The country flag -0.66
( moderate negative )
The country flag 0.84
( strong )
The country flag -0.33
( neutral )
The country flag 0.55
( weak )

Karuna Therapeutics Inc Financials

Annual 2023
Revenue: $654 000
Gross Profit: $-1.05M (-160.09 %)
EPS: $-11.73
FY 2023
Revenue: $654 000
Gross Profit: $-1.05M (-160.09 %)
EPS: $-11.73
FY 2022
Revenue: $10.64M
Gross Profit: $9.53M (89.55 %)
EPS: $-8.74
FY 2021
Revenue: $36.96M
Gross Profit: $36.96M (100.00 %)
EPS: $-5.44

Financial Reports:

No articles found.

Karuna Therapeutics Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Karuna Therapeutics Inc

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company, and Zai Lab (Shanghai) Co., Ltd; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators